Tendon Allograft Market Report 2025

The tendon allograft market size has grown rapidly in recent years. It will grow from $1.38 billion in 2024 to $1.53 billion in 2025 at a compound annual growth rate (CAGR) of 11%. The growth during the historic period can be attributed to increasing awareness of tendon repair procedures, a rising prevalence of sports injuries, growth in orthopedic surgeries, increasing demand for minimally invasive surgeries, and greater availability of allograft tissues.

The tendon allograft market size is expected to see rapid growth in the next few years. It will grow to $2.29 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to rising focus on joint preservation surgeries, increasing adoption of tissue engineering, rising prevalence of musculoskeletal disorders, increasing government support for regenerative medicine, and rising demand for customized tendon allografts. Major trends in the forecast period include advancement in tissue processing technologies, advanced graft customization techniques, innovation in scaffold materials, integration of 3d printing with tendon grafts, and innovation in biologics to enhance graft acceptance.

The increasing prevalence of sports injuries is anticipated to drive the growth of the tendon allograft market in the coming years. Sports injuries are physical injuries that occur during athletic activities or exercise, impacting muscles, ligaments, tendons, bones, or joints. The frequency of such injuries is rising as more people participate in sports and physical activities, increasing their exposure to potential harm. Tendon allografts facilitate recovery from sports injuries by providing ready-to-use tendon tissue for surgical repair, making them particularly suitable for athletes and active individuals. They help restore tendon function by supporting tissue integration and healing, enhancing mobility, and speeding up the return to sports. For example, according to the U.S. National Safety Council, the number of sports and recreational injuries in the United States reached 564,845 in 2024, up from 482,886 in 2023. Consequently, the growing incidence of sports injuries is fueling the expansion of the tendon allograft market.

Key players in the tendon allograft market are concentrating on developing advanced products, such as bioengineered grafts, to improve tissue integration and healing. Bioengineered grafts are lab-created or modified tissues designed to replace or repair damaged tissues, promoting healing and restoring functionality. For example, in July 2022, AlloSource Inc., a US-based nonprofit organization, introduced a new quadriceps tendon allograft as part of its AlloConnex line of tendons, ligaments, and fascia. This product line provides a comprehensive range of bioengineered tissues, including Achilles, anterior tibialis, gracilis, peroneus longus, posterior tibialis, semitendinosus, quadriceps, and patellar ligaments, in various configurations such as single strand, double strand, double bundle, and pre-shaped options to meet diverse surgical requirements. All tissues are processed using AlloSource’s proprietary AlloTrue cleansing method, which effectively removes blood and lipids and reduces viable microorganisms while preserving the essential biomechanical properties required for successful transplantation. The quadriceps tendon offers a strong option for cruciate ligament procedures and is available with or without a bone block to support different surgical techniques.

In August 2023, Coloplast A/S, a Denmark-based healthcare company, acquired Kerecis Limited for an undisclosed sum. Through this acquisition, Coloplast A/S aims to strengthen its position in the advanced wound care market by entering the fast-growing US-centric biologics segment with a sustainable, clinically differentiated fish-skin technology, thereby driving long-term growth and broadening its tissue regeneration product portfolio. Kerecis Limited, an Iceland-based biotechnology firm, offers a tendon allograft product called SurgiBind Tendon Protect.

Major players in the tendon allograft market are Medtronic plc, Stryker Corporation, Stryker Corporation, Regeneration Technologies Inc., Zimmer Biomet Holdings Inc., Smith & Nephew plc, Arthrex Inc., Conmed Corporation, MTF Biologics, Orthofix Medical Inc., B. Braun Melsungen AG, MiMedx Group Inc., LifeNet Health Inc., AlloSource Inc., Xtant Medical Holdings Inc., Vivex Biomedical Inc., JRF Ortho Inc., Bone Bank Allografts, Curasan AG, EvoLogics GmbH.

North America was the largest region in the tendon allograft market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in tendon allograft market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the tendon allograft market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

A tendon allograft is a surgical graft in which a tendon is taken from a donor and transplanted into a patient to repair or replace a damaged or ruptured tendon. Its primary function is to restore tendon strength, function, and mobility, particularly in cases where the patient’s own tendon tissue is insufficient or unsuitable for repair.

The main types of tendon allografts include flexor tendons, extensor tendons, patellar tendons, Achilles tendons, and other varieties. Flexor tendons are strong, fibrous cords that connect muscles to bones, enabling the bending (flexion) of fingers and toes. Tendon allografts are available in various forms, including soft tissue allografts, cartilage allografts, and bone allografts, and are applied in orthopedic, dental, cardiovascular, wound care, and other medical fields. They are distributed through multiple channels such as direct sales, distributors, online platforms, surgical centers, and hospitals, and serve end-users including hospitals, ambulatory surgical centers, specialty clinics, rehabilitation centers, and research institutions.

The tendon allograft market research report is one of a series of new reports that provides tendon allograft market statistics, including tendon allograft industry global market size, regional shares, competitors with a tendon allograft market share, detailed tendon allograft market segments, market trends and opportunities, and any further data you may need to thrive in the tendon allograft industry. This tendon allograft market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tendon allograft market consists of sales of fresh frozen tendon allografts, freeze-dried tendon allografts, demineralized tendon allografts, processed tendon allografts with sterilization, and composite tendon allografts. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.